does caresource cover glp-1 GLP-1s prescriptions for weight loss are skyrocketing in North Carolina California Ends Medicaid Coverage of

I'm optimistic about where obesity pharmacotherapy is headed

Baseline liver enzyme assessment is reasonable for patients with: Pre-existing liver disease or elevated baseline transaminases Metabolic syndrome or clinical features suggesting MASLD Concurrent use of other potentially hepatotoxic medications Obesity (BMI 30 kg/m) with additional metabolic risk factors History of excessive alcohol consumption For patients with abnormal baseline liver enzymes, periodic monitoring every 3-6 months during the first year of therapy allows clinicians to assess treatment response and detect any unexpected changes

But as you look for ways to support your levels, you will quickly encounter a choice: standard glutathione versus the liposomal version

You dont need to worry about the technical detailsour medical team will assess your eligibility and clearly explain your options